As of Nov 2, 2026: Christoph Samuel Ziegler (Director, VRXA) reported 1 buy for $33K in the last 12 months (Form 4). VRXA's Quality Score is 3. Scores as of 7:43 PM ET, 15 minutes behind.

Christoph Samuel Ziegler

Director of Veraxa Biotech AG

1 stock trade in the last 12 months, shares they bought or sold themselves (not grants or options).

Bought$33K12 months Sold$012 months Last filedOct 21a buy

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Christoph Samuel Ziegler reported

Newest first, as filed

Stock	Trade	Amount	Trade	Shares	Traded Filed
VRXAVeraxa Biotech	Buy	$33Kat $1.09	Buy$33Kat $1.09	30,000 at $1.09	Oct 20filed Oct 21SEC filing

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See the tradeSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Christoph Samuel Ziegler's companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
VRXAVeraxa BiotechDirector	Directorfiled Oct 21	1	3

Alerts for Christoph Samuel Ziegler

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Oct 21, 2026.

Free to reuse with a link to this page.

How to cite

Breakaway, Christoph Samuel Ziegler: Director at VRXA, insider trades, Oct 21, 2026, getbreakaway.com/insiders/christoph-samuel-ziegler

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at Veraxa Biotech AG

Insider trades by person